Intrexon reported $20M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acceleron Pharma XLRN:US $ 35.47M 4.41M
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Agenus AGEN:US $ 16.65M 298K
Amgen AMGN:US $ 1.38B 130M
Anika Therapeutics ANIK:US $ 17.99M 186K
Arrowhead Research ARWR:US $ 17.86M 1.67M
AstraZeneca AZN:LN 2.57B 76M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Chemocentryx CCXI:US $ 19.7M 3.44M
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Flexion Therapeutics FLXN:US $ 27.41M 189K
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Heron Therapeutics HRTX:US $ 33.16M 8.35M
Immunogen IMGN:US $ 9.73M 481K
Intrexon XON:US $ 20M 1.3M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Ligand Pharmaceuticals LGND:US $ 14.71M 2.09M
Macrogenics MGNX:US $ 15.23M 198K
Mannkind MNKD:US $ 20.06M 2.64M
Merk MRK:US $ 2.25B 376M
Novartis NOVN:VX 3.71B 190M
Peregrine Pharmaceuticals PPHM:US $ 4.46M 595K
Rigel Pharmaceuticals RIGL:US $ 22.38M 257K
Sangamo Biosciences SGMO:US $ 16.49M 338K
Thermo Fisher Scientific TMO:US $ 1.61B 196M
Veracyte VCYT:US $ 19.91M 639K
Xencor XNCR:US $ 8.86M 637K
YTE INCY:US $ 168.86M 15.06M
Ziopharm Oncology ZIOP:US $ 9.07M 842K